B CELL LEUKEMIA
Clinical trials for B CELL LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new B CELL LEUKEMIA trials appear
Sign up with your email to follow new studies for B CELL LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Engineered immune cells take on childhood leukemia in early trial
Disease control OngoingThis early-stage study tests a new treatment for children and young adults with relapsed B-cell leukemia. The approach uses a patient's own immune cells, modified to recognize and attack leukemia cells. The main goals are to check safety and find the best dose, with a secondary l…
Matched conditions: B CELL LEUKEMIA
Phase: PHASE1 • Sponsor: Seattle Children's Hospital • Aim: Disease control
Last updated Jun 16, 2026 12:54 UTC
-
Off-the-Shelf cell therapy takes on tough blood cancers
Disease control TerminatedThis early-phase study tests a "universal" CAR-T cell therapy (UWD-CD19) for people with B-cell cancers that haven't responded to standard treatments. About 30 participants will receive a single infusion of these engineered immune cells after a short chemotherapy prep. The main g…
Matched conditions: B CELL LEUKEMIA
Phase: EARLY_PHASE1 • Sponsor: Wondercel Biotech (ShenZhen) • Aim: Disease control
Last updated Jun 16, 2026 12:51 UTC